Markey Cancer Center Molecular Tumor Board (MTB)
The Markey Cancer Center Molecular Tumor Board (MTB) is a statewide service available to physicians at UK HealthCare and regional affiliates.
The MTB provides a forum for expert clinicians, pathologists and scientists to discuss and analyze tumor genotypes and molecular abnormalities in order to recommend patient specific targeted therapies.
The MTB is intended to supplement oncology tumor boards and includes a broad range of expert panel members.
Clinicians can order a genomic report and submit a case study to be presented for review by the MTB during their twice monthly meetings. More information on ordering reports will be available in February.
- Jill Kolesar, PharmD, MS, Co-Director
- Rachel Miller, MD, Co-Director
Click here to contact the MTB by email, or
email Dr. Kolesar directly.